NH Lawmakers Consider Psilocybin Legalization Bills

New Hampshire lawmakers heard testimony this week on two bipartisan bills that would legalize psilocybin for medical use, potentially making the state one of the first to allow therapeutic access to the psychedelic compound.

The House Health, Human Services and Elderly Affairs Committee considered HB 1809, sponsored by Rep. Buzz Scherr (D), and HB 1796, introduced by Rep. Michael Sylvia (R).

"This is not a partisan issue," Scherr told the committee. "It's about providing additional options for those in need."

What the Bills Propose

Both bills would create a regulated framework for patients to access psilocybin—the active compound in psychedelic mushrooms—under medical supervision. The proposals come as clinical research continues to show promise for psilocybin in treating depression, anxiety, PTSD, and end-of-life distress.

Sylvia emphasized the importance of establishing proper safeguards. His bill focuses on ensuring patients can access psilocybin through licensed facilities with trained practitioners.

The Hearing

The committee heard from a range of witnesses including medical professionals, veterans, and patients who described their experiences with psilocybin therapy—often obtained through clinical trials or in states with existing programs.

Several veterans testified about using psilocybin to treat combat-related PTSD after conventional treatments failed. Mental health advocates argued the compound could fill gaps in existing treatment options.

Opponents raised concerns about safety oversight and the potential for misuse, though supporters noted that the bills specifically require medical supervision rather than allowing recreational access.

Broader Context

Oregon became the first state to legalize therapeutic psilocybin in 2020, with licensed service centers opening in 2023. Colorado followed with a broader measure that includes personal use provisions.

Several other states are considering similar legislation, and the FDA has granted "breakthrough therapy" designation to psilocybin for treatment-resistant depression, signaling potential federal approval could come within years.

The New Hampshire bills will undergo further committee review before any floor vote.

This article is based on original reporting by Marijuana Moment.